LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 116 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,039 | -16.3% | 83,931 | 0.0% | 0.02% | -18.5% |
| Q2 2023 | $118,343 | +6.7% | 83,931 | +13.5% | 0.03% | -3.6% |
| Q1 2023 | $110,897 | +12.9% | 73,931 | -11.9% | 0.03% | -12.5% |
| Q4 2022 | $98,199 | +3.4% | 83,931 | 0.0% | 0.03% | 0.0% |
| Q3 2022 | $95,000 | -24.0% | 83,931 | +6.3% | 0.03% | -22.0% |
| Q2 2022 | $125,000 | +6.8% | 78,931 | +4.0% | 0.04% | +20.6% |
| Q1 2022 | $117,000 | -10.0% | 75,931 | +43.5% | 0.03% | -10.5% |
| Q4 2021 | $130,000 | +7.4% | 52,931 | +10.4% | 0.04% | -5.0% |
| Q3 2021 | $121,000 | -11.7% | 47,931 | 0.0% | 0.04% | -13.0% |
| Q2 2021 | $137,000 | +29.2% | 47,931 | +6.7% | 0.05% | +9.5% |
| Q1 2021 | $106,000 | – | 44,931 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 5,036,720 | $14,354,000 | 4.77% |
| BROADWOOD CAPITAL INC | 34,005,379 | $96,915,000 | 4.33% |
| Prescott General Partners LLC | 1,851,851 | $5,278,000 | 0.17% |
| Raffles Associates | 43,590 | $124,000 | 0.10% |
| Laidlaw Wealth Management LLC | 123,730 | $353,000 | 0.09% |
| DCF Advisers, LLC | 74,500 | $212,000 | 0.08% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $128,000 | 0.07% |
| Strategic Wealth Investment Group, LLC | 64,232 | $183,000 | 0.06% |
| Paradigm, Strategies in Wealth Management, LLC | 19,775 | $56,000 | 0.05% |
| Fort Sheridan Advisors LLC | 47,931 | $137,000 | 0.05% |